Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors

Clinical trial NCT02499952 · TERMINATED

Trial details

NCT number: NCT02499952
Sponsor: Nasser Hanna, M.D.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Germ Cell Neoplasms Testicular Neoplasms Non Seminomatous Germ Cell Tumors Mediastinal Neoplasms Genital Neoplasms, Male Genital Neoplasms, Female Ovarian Neoplasms

Start date: 2016-01-01
Primary completion: 2017-01-13
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.